Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MAX E MERCADO

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1336151182
CMS profile
151365
Location
PHILADELPHIA, PA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$13,338.80

246 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Page 2 of 5; records 51–100 of 246 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MAX E MERCADO

NPI 1336151182 · CMS profile ID 151365

Allopathic & Osteopathic Physicians / Internal Medicine

PHILADELPHIA, PA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 5; records 51–100 of 246 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1336151182?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MAX E MERCADO, NPI 1336151182, CMS profile ID 151365. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 246 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1336151182?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). MAX E MERCADO, NPI 1336151182, CMS profile ID 151365. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 246 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1336151182?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
MAX E MERCADO, NPI 1336151182, CMS profile ID 151365, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 5; records 51–100 of 246 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1336151182?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

246 matching records · $13,338.80 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 246 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 246.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $20.2710/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830070143 CMS
Lundbeck LLC $16.9610/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845923113 CMS
Novo Nordisk Inc $17.4610/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811608663 CMS
Genentech USA, Inc. $14.7310/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835949183 CMS
Novartis Pharmaceuticals Corporation $14.3910/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813077737 CMS
AbbVie Inc. $27.8110/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795655977 CMS
Amgen Inc. $16.6210/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825603781 CMS
Astellas Pharma US Inc $15.3110/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821448767 CMS
Novo Nordisk Inc $15.9010/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810788799 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.6810/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 850368825 CMS
AbbVie Inc. $12.7310/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795655971 CMS
AstraZeneca Pharmaceuticals LP $15.3310/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829831857 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $8.4910/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 850358685 CMS
Abbott Laboratories $22.8910/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815730359 CMS
Althera Pharmaceuticals LLC $10.4910/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 800371935 CMS
Eisai Inc. $15.7410/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818011019 CMS
OPKO Pharmaceuticals, LLC $21.5310/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827746555 CMS
GlaxoSmithKline, LLC. $16.0610/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 801686243 CMS
OPKO Pharmaceuticals, LLC $1.0010/05/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 859336899 CMS
OPKO Pharmaceuticals, LLC $0.7910/05/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 859336901 CMS
ARBOR PHARMACEUTICALS, INC. $15.8710/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830932053 CMS
Bayer HealthCare Pharmaceuticals Inc. $18.4010/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 789105553 CMS
Teva Pharmaceuticals USA, Inc. $14.0710/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839644571 CMS
Lilly USA, LLC $17.2409/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818587621 CMS
Alfasigma USA, Inc. $58.6509/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 853050271 CMS
AbbVie Inc. $19.0009/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795655965 CMS
AstraZeneca Pharmaceuticals LP $14.1509/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829827277 CMS
OPKO Pharmaceuticals, LLC $0.7909/23/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 859336897 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.4509/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763707092 CMS
Sunovion Pharmaceuticals Inc. $11.6509/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821881139 CMS
AbbVie Inc. $7.6409/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795655959 CMS
Novo Nordisk Inc $20.4409/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811464956 CMS
Novo Nordisk Inc $13.8009/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811608657 CMS
Novo Nordisk Inc $3.1809/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811703821 CMS
Lilly USA, LLC $8.0809/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818658159 CMS
Lilly USA, LLC $15.0109/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818650425 CMS
Astellas Pharma US Inc $16.8409/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821448761 CMS
Janssen Pharmaceuticals, Inc $23.8209/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788124531 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $13.1109/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 850228899 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $10.2509/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 850349353 CMS
ARBOR PHARMACEUTICALS, INC. $15.7109/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830932039 CMS
AstraZeneca Pharmaceuticals LP $18.4009/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829879725 CMS
GlaxoSmithKline, LLC. $20.1709/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 801688341 CMS
PFIZER INC. $14.9309/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833499217 CMS
PFIZER INC. $14.9309/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833441807 CMS
AstraZeneca Pharmaceuticals LP $15.9009/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829746561 CMS
Biohaven Pharmaceuticals, Inc. $1,200.0008/28/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852566171 CMS
OPKO Pharmaceuticals, LLC $24.5508/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827746553 CMS
OPKO Pharmaceuticals, LLC $0.7908/26/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 859336895 CMS
Novartis Pharmaceuticals Corporation $19.5008/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813077733 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $6,611.61 242
PY2020 $6,274.46 198
PY2021 $13,338.80 246
PY2022 $4,567.95 224
PY2023 $12,838.54 231
PY2024 $5,235.78 194
PY2025 $3,103.67 180

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $76,552.22 31
PY2024 Principal investigator $141,523.89 39
PY2023 Principal investigator $294,841.60 32

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

31 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Currax Pharmaceuticals LLC $558.90 12/04/2025 Non-covered Recipient Entity
Qcare Site Services Inc
NB (Contrave) Cardiovascular Outcomes Trial No dispute reported 06/30/2026 1242717031
Principal investigator 1 Currax Pharmaceuticals LLC $800.00 10/14/2025 Non-covered Recipient Entity
Qcare Site Services Inc
NB (Contrave) Cardiovascular Outcomes Trial No dispute reported 06/30/2026 1242716983
Principal investigator 1 Genentech, Inc. $22.00 09/26/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211589929
Principal investigator 1 Genentech, Inc. $3,800.00 09/24/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211589925
Principal investigator 1 Exact Sciences Corporation $4,500.00 08/29/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS LLC
Informed Choice Intervention for Colorectal Cancer Screening: COMPASS No dispute reported 06/30/2026 1244037491
Principal investigator 1 AstraZeneca Pharmaceuticals LP $5,000.00 07/16/2025 Non-covered Recipient Entity
MERCADO MEDICAL PRACTICE
a phase 3,global,randomized,modified double blind,placebo controlled,study to evaluate the efficacy,immunogenicity,and safety of IVX A12,a respiratory syncytial virus RSV and human metapneumovirus hMPV virus like particle VLP vaccine in adults 60 years of age and older No dispute reported 06/30/2026 1185555585
Principal investigator 1 Novartis Pharmaceuticals Corporation $1,500.00 07/01/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS LLC
Randomized, Double-blind, Placebo-controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (VICTORION-2 PREVENT) No dispute reported 06/30/2026 1190311171
Principal investigator 1 Novartis Pharmaceuticals Corporation $59.93 06/30/2025 Non-covered Recipient Entity
CCT RESEARCH
Randomized, Double-blind, Placebo-controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (VICTORION-2 PREVENT) No dispute reported 06/30/2026 1190312591
Principal investigator 1 AstraZeneca Pharmaceuticals LP $6,745.00 06/27/2025 Non-covered Recipient Entity
QCARE SITE SERVICES INC
Levante A Phase 2b Randomised Double Blind Placebo Controlled Dose Range Finding Study to Assess Efficacy and Safety of Multiple Dose Levels of Inhaled AZD8630 No dispute reported 06/30/2026 1185555587
Principal investigator 1 Currax Pharmaceuticals LLC $1,654.62 06/24/2025 Non-covered Recipient Entity
Qcare Site Services Inc
NB (Contrave) Cardiovascular Outcomes Trial No dispute reported 06/30/2026 1242716979
Principal investigator 1 Currax Pharmaceuticals LLC $276.00 06/19/2025 Non-covered Recipient Entity
Qcare Site Services Inc
NB (Contrave) Cardiovascular Outcomes Trial No dispute reported 06/30/2026 1242716911
Principal investigator 1 Currax Pharmaceuticals LLC $1,324.80 05/28/2025 Non-covered Recipient Entity
Qcare Site Services Inc
NB (Contrave) Cardiovascular Outcomes Trial No dispute reported 06/30/2026 1242716907
Principal investigator 1 Currax Pharmaceuticals LLC $5,727.69 04/24/2025 Non-covered Recipient Entity
Qcare Site Services Inc
NB (Contrave) Cardiovascular Outcomes Trial No dispute reported 06/30/2026 1242716947
Principal investigator 1 Currax Pharmaceuticals LLC $2,639.00 04/04/2025 Non-covered Recipient Entity
Qcare Site Services Inc
NB (Contrave) Cardiovascular Outcomes Trial No dispute reported 06/30/2026 1242716905
Principal investigator 1 Currax Pharmaceuticals LLC $3,310.62 03/27/2025 Non-covered Recipient Entity
Qcare Site Services Inc
NB (Contrave) Cardiovascular Outcomes Trial No dispute reported 06/30/2026 1242716857
Principal investigator 1 Currax Pharmaceuticals LLC $372.60 03/27/2025 Non-covered Recipient Entity
Qcare Site Services Inc
NB (Contrave) Cardiovascular Outcomes Trial No dispute reported 06/30/2026 1242716863
Principal investigator 1 Genentech, Inc. $324.00 03/26/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211589126
Principal investigator 1 Genentech, Inc. $86.00 03/21/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211589065
Principal investigator 1 Genentech, Inc. $200.00 03/05/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211589082
Principal investigator 1 Currax Pharmaceuticals LLC $750.00 02/27/2025 Non-covered Recipient Entity
Qcare Site Services Inc
NB (Contrave) Cardiovascular Outcomes Trial No dispute reported 06/30/2026 1242716765
Principal investigator 1 Currax Pharmaceuticals LLC $331.20 02/27/2025 Non-covered Recipient Entity
Qcare Site Services Inc
NB (Contrave) Cardiovascular Outcomes Trial No dispute reported 06/30/2026 1242716771
Principal investigator 1 Currax Pharmaceuticals LLC $186.30 02/27/2025 Non-covered Recipient Entity
Qcare Site Services Inc
NB (Contrave) Cardiovascular Outcomes Trial No dispute reported 06/30/2026 1242716781
Principal investigator 1 Currax Pharmaceuticals LLC $8,580.54 02/20/2025 Non-covered Recipient Entity
Qcare Site Services Inc
NB (Contrave) Cardiovascular Outcomes Trial No dispute reported 06/30/2026 1242716833
Principal investigator 1 Exact Sciences Corporation $1,000.00 01/31/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS LLC
Informed Choice Intervention for Colorectal Cancer Screening: COMPASS No dispute reported 06/30/2026 1244037487
Principal investigator 1 Genentech, Inc. $750.00 01/29/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211589231
Principal investigator 1 Genentech, Inc. $527.00 01/14/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211589146
Principal investigator 1 Genentech, Inc. $527.00 01/13/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211589336
Principal investigator 1 AstraZeneca Pharmaceuticals LP $22,390.00 01/08/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS
Levante A Phase 2b Randomised Double Blind Placebo Controlled Dose Range Finding Study to Assess Efficacy and Safety of Multiple Dose Levels of Inhaled AZD8630 No dispute reported 06/30/2026 1185555591
Principal investigator 1 ModernaTX, Inc. $1,272.52 01/03/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS LLC
A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults No dispute reported 06/30/2026 1252964130
Principal investigator 1 ModernaTX, Inc. $621.00 01/03/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS LLC
A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults No dispute reported 06/30/2026 1252964132
Principal investigator 1 ModernaTX, Inc. $715.50 01/03/2025 Non-covered Recipient Entity
COGNITIVE CLINICAL TRIALS LLC
A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults No dispute reported 06/30/2026 1252964134